PELLEGRINI, PATRIZIA
PELLEGRINI, PATRIZIA
FARMACOLOGIA TRASLAZIONALE - IFT
A gender-related action of IFNß-therapy was found in multiple sclerosis.
2012 Contasta, I; Totaro, R; Pellegrini, P; DEL BEATO, T; Berghella, Am
Absence of serum HTLV-I and -III antibodies in multipe sclerosis patients
1986 Salerni, E; Bernabei, R; D'Aurizio, C; D'Andrea, F; Adorno, D; Pellegrini, P; Berghella, Am; Maschio, C; Prencipe, M
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age
2014 Berghella A.M.; Contasta I.; Marulli G.; D'Innocenzo C.; Garofalo F.; Gizzi F.; Bartolomucci M.; Laglia G.; Valeri M.; Gizzi M.; Friscioni M.; Barone M.; Del Beato T.; Secinaro E.; Pellegrini P.
Analisi del DNA heteroduplex per il locus HLA-DP nel trapianto di midollo osseo.
1993 PAPOLA F.; LIBERATORE G.; DI BARTOLOMEO P.; CONTASTA I.; DI ROCCO M.; PELLEGRINI P.; ADORNO D.; CASCIANI C. U
Analisi longitudinale delle sottopopolazioni T-linfocitarie nella Sclerosi Multipla.
1985 SALERNI E; PRENCIPE M; D'AURIZIO C; PELLEGRINI P; BERGHELLA AM; ADORNO D
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
2006 Berghella, Am; Contasta, I; Pellegrini, P; DEL BEATO, T; Adorno, D
Attività linfocitaria nella schizofrenia: uno studio controllato
1992 Di Michele, V; Bolino, F; Conte, I; Cupillari, M; Pellegrini, P; Piancatelli, D; Del Beato, T; De Cataldo, S; Adorno, D; Casciani, Cu; Casacchia, M
Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated.
1998 Berghella, Am; Pellegrini, P; Contasta, I; DEL BEATO, T; Adorno, D
Blockade of N Methyl D-Aspartate receptor prevents Hypoxic Neuronal dath and Cytokine release.
1997 DI LORETO, S; Balestrino, M; Pellegrini, P; Berghella, Am; DEL BEATO, T; DI MARCO, F; Adorno, D
Bone marrow transplantation in siblings:correlation of MLC, serological and DNA typing
1992 Piancatelli, D; Del Beato, T; Di Bartolomeo, P; Pellegrini, P; Lepidi, D; Di Rocco, M; Cococcetta, Ur; Angrilli, F; Adorno, D; Casciani, Cu
Cancer establishment and progression
1995 Pellegrini P; Berghella AM; Piancatelli D; Del Beato T; Adorno D; Casciani CU
Carcinoembryonic antigen and soluble interleukin-2 receptor in colon cancer
1993 Pellegrini P; Piancatelli D; Berghella AM; Del Beato T; Sebastiani P; Adorno D; Casciani CU
CD30 antigen: not a physiological marker for TH2 cells but animportant costimulator molecule in the regulation of the balance between TH1/TH2 response
2003 Pellegrini P; Berghella AM; Contatsta I; Adorno D.
CD30 Molecule, The Immune System and Multiple Sclerosis.
2008 BERGHELLA AM; PELLEGRINI P; CONTASTA I; CAROLEI A; ADORNO D
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance.
2005 Berghella, Am; Pellegrini, P; Contasta, I; Carolei, A; Adorno, D
CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response
2003 Pellegrini, P; Berghella, Am; Contasta, I; Adorno, D
Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules
2001 Contasta I.; Pellegrini P.; Berghella AM.; Adorno D.
Classification of cancer stage using the immune system.
2010 Pellegrini, P; Contasta, I; Berghella, Am; Del Beato, T; Adorno, D
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy
2006 Contasta, I; Pellegrini, P; Berghella, Am; DEL BEATO, T; Adorno, D
Colon cancer: hypotesis of progression mechanism
1993 Berghella AM; Pellegrini P; Piancatelli D; Del Beato T; Adorno D; Casciani CU
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A gender-related action of IFNß-therapy was found in multiple sclerosis. | 1-gen-2012 | Contasta, I; Totaro, R; Pellegrini, P; DEL BEATO, T; Berghella, Am | |
| Absence of serum HTLV-I and -III antibodies in multipe sclerosis patients | 1-gen-1986 | Salerni, E; Bernabei, R; D'Aurizio, C; D'Andrea, F; Adorno, D; Pellegrini, P; Berghella, Am; Maschio, C; Prencipe, M | |
| Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age | 1-gen-2014 | Berghella A.M.; Contasta I.; Marulli G.; D'Innocenzo C.; Garofalo F.; Gizzi F.; Bartolomucci M.; Laglia G.; Valeri M.; Gizzi M.; Friscioni M.; Barone M.; Del Beato T.; Secinaro E.; Pellegrini P. | |
| Analisi del DNA heteroduplex per il locus HLA-DP nel trapianto di midollo osseo. | 1-gen-1993 | PAPOLA F.; LIBERATORE G.; DI BARTOLOMEO P.; CONTASTA I.; DI ROCCO M.; PELLEGRINI P.; ADORNO D.; CASCIANI C. U | |
| Analisi longitudinale delle sottopopolazioni T-linfocitarie nella Sclerosi Multipla. | 1-gen-1985 | SALERNI E; PRENCIPE M; D'AURIZIO C; PELLEGRINI P; BERGHELLA AM; ADORNO D | |
| Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? | 1-gen-2006 | Berghella, Am; Contasta, I; Pellegrini, P; DEL BEATO, T; Adorno, D | |
| Attività linfocitaria nella schizofrenia: uno studio controllato | 1-gen-1992 | Di Michele, V; Bolino, F; Conte, I; Cupillari, M; Pellegrini, P; Piancatelli, D; Del Beato, T; De Cataldo, S; Adorno, D; Casciani, Cu; Casacchia, M | |
| Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated. | 1-gen-1998 | Berghella, Am; Pellegrini, P; Contasta, I; DEL BEATO, T; Adorno, D | |
| Blockade of N Methyl D-Aspartate receptor prevents Hypoxic Neuronal dath and Cytokine release. | 1-gen-1997 | DI LORETO, S; Balestrino, M; Pellegrini, P; Berghella, Am; DEL BEATO, T; DI MARCO, F; Adorno, D | |
| Bone marrow transplantation in siblings:correlation of MLC, serological and DNA typing | 1-gen-1992 | Piancatelli, D; Del Beato, T; Di Bartolomeo, P; Pellegrini, P; Lepidi, D; Di Rocco, M; Cococcetta, Ur; Angrilli, F; Adorno, D; Casciani, Cu | |
| Cancer establishment and progression | 1-gen-1995 | Pellegrini P; Berghella AM; Piancatelli D; Del Beato T; Adorno D; Casciani CU | |
| Carcinoembryonic antigen and soluble interleukin-2 receptor in colon cancer | 1-gen-1993 | Pellegrini P; Piancatelli D; Berghella AM; Del Beato T; Sebastiani P; Adorno D; Casciani CU | |
| CD30 antigen: not a physiological marker for TH2 cells but animportant costimulator molecule in the regulation of the balance between TH1/TH2 response | 1-gen-2003 | Pellegrini P; Berghella AM; Contatsta I; Adorno D. | |
| CD30 Molecule, The Immune System and Multiple Sclerosis. | 1-gen-2008 | BERGHELLA AM; PELLEGRINI P; CONTASTA I; CAROLEI A; ADORNO D | |
| CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. | 1-gen-2005 | Berghella, Am; Pellegrini, P; Contasta, I; Carolei, A; Adorno, D | |
| CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response | 1-gen-2003 | Pellegrini, P; Berghella, Am; Contasta, I; Adorno, D | |
| Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules | 1-gen-2001 | Contasta I.; Pellegrini P.; Berghella AM.; Adorno D. | |
| Classification of cancer stage using the immune system. | 1-gen-2010 | Pellegrini, P; Contasta, I; Berghella, Am; Del Beato, T; Adorno, D | |
| Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy | 1-gen-2006 | Contasta, I; Pellegrini, P; Berghella, Am; DEL BEATO, T; Adorno, D | |
| Colon cancer: hypotesis of progression mechanism | 1-gen-1993 | Berghella AM; Pellegrini P; Piancatelli D; Del Beato T; Adorno D; Casciani CU |